Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 244-435-6 | CAS number: 21544-03-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 04-Nov-2011 to 25-Jan-2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study has been performed according to OECD and/or EC guidelines and according to GLP principles.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Bis(2,3-epoxypropyl) cyclohexane-1,2-dicarboxylate
- EC Number:
- 226-826-3
- EC Name:
- Bis(2,3-epoxypropyl) cyclohexane-1,2-dicarboxylate
- Cas Number:
- 5493-45-8
- Molecular formula:
- C14H20O6
- IUPAC Name:
- bis(oxiran-2-ylmethyl) cyclohexane-1,2-dicarboxylate
- Reference substance name:
- 1,2-Cyclohexanedicarboxylic acid, 1-(3,2-dihydroxypropyl) 2-(2-oxiranylmethyl) ester
- Molecular formula:
- C14H22O7
- IUPAC Name:
- 1,2-Cyclohexanedicarboxylic acid, 1-(3,2-dihydroxypropyl) 2-(2-oxiranylmethyl) ester
- Reference substance name:
- 2-hydroxy-1,3-propanediyl bis[(oxiranylmethyl)-1,2-cyclohexanedicarboxylate
- Cas Number:
- 21799-33-7
- Molecular formula:
- C22H36O11
- IUPAC Name:
- 2-hydroxy-1,3-propanediyl bis[(oxiranylmethyl)-1,2-cyclohexanedicarboxylate
- Reference substance name:
- 2,3-Epoxypropyl 3-chloro-2-hydroxypropyl 1,2-cyclohexanedicarboxylate
- Cas Number:
- 52607-31-5
- Molecular formula:
- C14H21ClO6
- IUPAC Name:
- 2,3-Epoxypropyl 3-chloro-2-hydroxypropyl 1,2-cyclohexanedicarboxylate
- Reference substance name:
- 1,2-Cyclohexanedicarboxylic acid, 2-(2-oxiranylmethyl)-1,3-propanediyl bis(oxiranylmethyl) ester
- Molecular formula:
- C28H40O12
- IUPAC Name:
- 1,2-Cyclohexanedicarboxylic acid, 2-(2-oxiranylmethyl)-1,3-propanediyl bis(oxiranylmethyl) ester
- Reference substance name:
- 1,2-Cyclohexanedicarboxylic acid, 1-(2-chloromethyl)-1,2-ethanediyl bis(oxiranylmethyl) ester
- Molecular formula:
- C25H35ClO10
- IUPAC Name:
- 1,2-Cyclohexanedicarboxylic acid, 1-(2-chloromethyl)-1,2-ethanediyl bis(oxiranylmethyl) ester
- Test material form:
- liquid
Constituent 1
Constituent 2
Constituent 3
Constituent 4
Constituent 5
Constituent 6
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River, Sulzfeld, Germany
- Age at study initiation: 6 weeks
- Weight at study initiation: first main study 32 - 39 g and for the second main study 31 - 39 g
- Assigned to test groups randomly: yes
- Fasting period before study: yes
- Housing: In groups of 5 animals per sex per cage in polycarbonate cages containing sterilised sawdust as bedding material. Paper bedding was provided as cage-enrichment
- Diet (e.g. ad libitum): free access
- Water (e.g. ad libitum): free access
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18.3 - 21.8°C
- Humidity (%): 44 - 72%
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12 / 12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: corn oil
- Justification for choice of solvent/vehicle: Test compound was stable in corn oil and an emulsion could be obtained in corn oil. Corn oil has been accepted and approved by authorities and international guidelines
- Concentration of test material in vehicle: 43.8, 87.5, 150 and 175 mg/ml
- Amount of vehicle (if gavage or dermal): The dosing volume was 10 ml/kg body weight - Duration of treatment / exposure:
- First experiment:
Treatment:
Solvent, positive control, low and mid dose level: 24 hours
Highest dose level: 24 and 48 hours
Second experiment
Treatment:
Solvent, positive control and dose level: 48 hours - Frequency of treatment:
- Once
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
First experiment: 438, 875 and 1750 mg/kg BW
Basis:
nominal conc.
- Remarks:
- Doses / Concentrations:
Second experiment: 1500 mg/kg BW
Basis:
nominal conc.
- No. of animals per sex per dose:
- At leasr five animals per dose
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide
- Justification for choice of positive control(s):
- Route of administration: Oral
- Doses / concentrations: 40 mg/kg body weight
Examinations
- Tissues and cell types examined:
- Bone marrow smears
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
-The dose level selected should be ideally be the maximum tolerated dose level or that which produces some evidence of toxicity up to a maximum recommended dose of 2000 mg/kg.
DETAILS OF SLIDE PREPARATION:
- The smears are air-dried, fixed in methanol and stained using the "Wright-stain-procedure" in an "Ames" HEMA-tek slide stainer, allowed to air-dry and vover-slipped using mounting medium.
METHOD OF ANALYSIS:
- The number of micronucleated polychromatic erythrocytes was counted in 2000 polychromatic erythrocytes. The ratio of polychromatic to normochromatic erythrocytes was determined by counting and differentiating the first 1000 erythrocytes at the same time. Micronuclei were only counted in polychromatic erythrocytes. - Evaluation criteria:
- A test substance is considered positive in the micronucleus test if:
-It induced a biologically as well as a statistically significant (Wilcoxon Rank Sum Test, one-sided, p < 0.05) increase in the frequency of micronucleated polychromatic erythrocytes (at any dose or at any sampling time) and the number of micronucleated polychromatic erythrocytes in the animals are above the historical control data range.
A test substance is considered negative in the micronucleus test if:
- None of the tested concentrations or sampling times showed a statistically significant (Wilcoxon Rank Sum Test, one-sided, p < 0.05) increase in the incidence of micronucleated polychromatic erythrocytes and the number of micronucleated polychromatic erythrocytes in the animals are within the historical control data range. - Statistics:
- Wilcoxon Rank Sum Test, one-sided, p < 0.05
Results and discussion
Test results
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- yes
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: 1500, 1750, 1875 and 2000 mg/kg BW
- Clinical signs of toxicity in test animals:
In the dose range finding test, one animal per sex was dosed with 2000 mg bis(2,3-epoxypropyl) cyclohexane-1,2-dicarboxylate per kilogram body weight. The animals died within 21 hours after dosing. One animal per sex dosed with 1500 mg bis(2,3-epoxypropyl) cyclohexane-1,2-dicarboxylate per kilogram body weight showed the following toxic sign: hunched posture.
In total 3 animals per sex were dosed with 1750 mg bis(2,3-epoxypropyl) cyclohexane-1,2-dicarboxylate per kilogram body weight. Initially, one male and one female dosed with 1750 mg
bis(2,3-epoxypropyl) cyclohexane-1,2-dicarboxylate per kilogram body weight showed the following toxic signs after dosing: lethargy, rough coat and hunched posture.
One male and one female animal dosed with 1875 mg bis(2,3-epoxypropyl) cyclohexane-1,2-dicarboxylate per kilogram body weight died within 20 and 5 hours, respectively.
Two additional males and females dosed with 1750 mg/kg body weight showed the following toxic signs after dosing: lethargy, hunched posture and rough coat (2 males, 1 female).
RESULTS OF DEFINITIVE STUDY
- Clinical signs of toxicity in test animals:
First experiment: The animals dosed with 1750 mg/kg body weight showed the following toxic signs after dosing: hunched posture, rough coat (7 animals), lehargy (7 animals), closed eyes (2 animals), ventral recumbency (2 animals) and a low body temperature (2 animals). Seven animals died within 24 hours after dosing. No treatment related clinical signs or mortality were noted in the animals treated with 875 and 438 mg bis(2,3-epoxypropyl) cyclohexane-1,2-dicarboxylate per kg body weight
Second experiment:
The animals showed the following toxic signs after dosing: hunched posture and rough coat (3 animals). One animal died within 18 hours after dosing.
- Induction of micronuclei (for Micronucleus assay):
No biologically relevant increase in the mean frequency of micronucleated polychromatic erythrocytes was observed in the bone marrow of animals treated with bis(2,3-epoxypropyl) cyclohexane-1,2-dicarboxylate.
- Ratio of PCE/NCE (for Micronucleus assay):
No decrease in the ratio of polychromatic to normochromatic erythrocytes compared to the concurrent vehicle control group, indicating a lack of toxic effects of this test substance on erythropoiesis. However, the clinical signs observed were taken to indicate that systemic absorption had occurred
- Appropriateness of dose levels and route: Adequate evidence of test material toxicity was demonstrated via the oral route administration.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
bis(2,3-epoxypropyl) cyclohexane-1,2-dicarboxylate is not clastogenic or aneugenic in the bone marrow micronucleus test when sampled at 24 and 48 hours post dosing of male mice up to a dose of 1750 mg/kg and 1500 mg/kg, respectively (the maximum tolerated dose in accordance with current regulatory guidelines) - Executive summary:
No biologically relevant increase in the mean frequency of micronucleated polychromatic erythrocytes was observed in the bone marrow of animals treated with bis(2,3-epoxypropyl) cyclohexane-1,2-dicarboxylate.
The incidence of micronucleated polychromatic erythrocytes in the bone marrow of all negative control animals were within the historical vehicle control data range. Cyclophosphamide, the positive control substance, induced a statistically significant increase in the number of micronucleated polychromatic erythrocytes. Hence, both criteria for an acceptable assay were met.
The groups that were treated with bis(2,3-epoxypropyl) cyclohexane-1,2-dicarboxylate showed no decrease in the ratio of polychromatic to normochromatic erythrocytes compared to the concurrent vehicle control group, indicating a lack of toxic effects of this test substance on erythropoiesis. The groups that were treated with cyclophosphamide showed an expected decrease in the ratio of polychromatic to normochromatic erythrocytes compared to the vehicle controls, demonstrating toxic effects on erythropoiesis.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)